Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 43.87%-45.56M | ---- | -20.25%-81.17M | ---- | -52.12%-67.5M | ---- | -8.42%-44.38M | ---- | 91.81%-40.93M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | -133.63%-9.66M | ---- | 71.74%-4.14M | ---- | -17.45%-14.64M | ---- | 25.38%-12.46M |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---2.99M | ---- | ---- | ---- | 48.38%-2.49M | ---- | ---4.82M |
| Investment loss (gain) | ---- | ---- | ---- | 63.51%-1.39M | ---- | ---3.82M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -63.27%415K | ---- | -29.68%1.13M | ---- | 834.30%1.61M | ---- | -81.16%172K | ---- | -35.29%913K |
| Impairment and provisions: | ---- | -62.24%22.94M | ---- | 49.00%60.76M | ---- | 78.75%40.78M | ---- | 191.25%22.81M | ---- | -96.91%7.83M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --16.26M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | --3.45M | ---- | ---- | ---- | ---- | ---- | -300.90%-9.15M | ---- | -80.59%4.55M |
| -Other impairments and provisions | ---- | -56.20%19.49M | ---- | 9.12%44.5M | ---- | 27.60%40.78M | ---- | 874.06%31.96M | ---- | -91.42%3.28M |
| Revaluation surplus: | ---- | -137.21%-1.7M | ---- | -44.97%4.56M | ---- | 157.31%8.29M | ---- | -9.65%3.22M | ---- | -9.10%3.57M |
| -Fair value of investment properties (increase) | ---- | -118.96%-803K | ---- | 355.38%4.24M | ---- | --930K | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | -374.23%-894K | ---- | -95.57%326K | ---- | 128.44%7.36M | ---- | -9.65%3.22M | ---- | -9.10%3.57M |
| Asset sale loss (gain): | ---- | 97.79%-323K | ---- | ---14.59M | ---- | ---- | ---- | 99.92%-9K | ---- | -293.94%-11.11M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.39M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 97.62%-323K | ---- | ---13.56M | ---- | ---- | ---- | -110.59%-9K | ---- | 103.50%85K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---1.03M | ---- | ---- | ---- | ---- | ---- | -3,611.45%-14.59M |
| Depreciation and amortization: | ---- | -92.34%972K | ---- | -6.63%12.69M | ---- | -2.83%13.59M | ---- | -4.08%13.98M | ---- | -45.36%14.58M |
| -Amortization of intangible assets | ---- | ---- | ---- | 14.05%836K | ---- | -11.04%733K | ---- | -16.60%824K | ---- | -92.36%988K |
| Financial expense | ---- | 663.49%481K | ---- | --63K | ---- | ---- | ---- | -80.56%7K | ---- | -35.71%36K |
| Exchange Loss (gain) | ---- | 91.63%-572K | ---- | -696.27%-6.83M | ---- | -121.88%-858K | ---- | 16.45%3.92M | ---- | 353.42%3.37M |
| Special items | ---- | ---- | ---- | ---- | ---- | 106.52%103K | ---- | -132.89%-1.58M | ---- | -96.60%4.8M |
| Operating profit before the change of operating capital | ---- | 37.65%-23.34M | ---- | -213.25%-37.44M | ---- | 37.00%-11.95M | ---- | 44.58%-18.97M | ---- | 63.58%-34.23M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -13.30%997K | ---- | 3,008.11%1.15M | ---- | 76.19%37K | ---- | -85.11%21K | ---- | -91.75%141K |
| Accounts receivable (increase)decrease | ---- | -10,370.56%-47.45M | ---- | -98.29%462K | ---- | 35.20%26.99M | ---- | -47.64%19.96M | ---- | -47.03%38.12M |
| Accounts payable increase (decrease) | ---- | 744.11%20M | ---- | 114.74%2.37M | ---- | -2,757.19%-16.08M | ---- | 102.17%605K | ---- | -42.17%-27.87M |
| prepayments (increase)decrease | ---- | 377.03%11.11M | ---- | -88.54%2.33M | ---- | -12.98%20.33M | ---- | 217.46%23.36M | ---- | 57.41%7.36M |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | -112.47%-1.39M | ---- | --11.17M | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | ---1.2M | ---- | ---- | ---- | 45.75%1.22M | ---- | 132.43%835K |
| Cash from business operations | ---- | -20.16%-38.69M | ---- | -205.58%-32.2M | ---- | 16.41%30.5M | -162.13%-21.16M | 267.46%26.2M | 73.30%-8.07M | 58.60%-15.64M |
| Other taxs | ---- | 5.25%-5.23M | ---- | 31.05%-5.52M | ---- | -1,167.20%-8M | ---6.5M | 118.37%750K | ---- | 77.64%-4.08M |
| Special items of business | -363.90%-123.23M | ---- | 913.39%46.7M | ---1.52M | ---5.74M | ---- | ---- | ---- | ---- | ---- |
| Adjustment items of business operations | ---- | ---- | ---- | --1.52M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -363.90%-123.23M | -16.44%-43.92M | 913.39%46.7M | -267.69%-37.72M | 79.25%-5.74M | -16.54%22.49M | -242.66%-27.66M | 236.60%26.95M | 73.47%-8.07M | 64.80%-19.73M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | ---- | 123.24%6.47M | ---- | -30.66%2.9M | -59.85%1.62M | -48.50%4.18M | -13.14%4.03M | -36.64%8.12M |
| Dividend received - investment | ---- | ---- | ---- | --2.99M | ---- | ---- | ---- | ---- | --2.49M | --4.82M |
| Loan receivable (increase) decrease | ---- | 7,630.90%79.55M | ---- | -48.88%1.03M | ---- | -80.89%2.01M | -42.86%19.09M | 2,351.28%10.54M | 471.73%33.4M | -103.45%-468K |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---84.54M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | --370K | -98.44%323K | ---- | --20.72M | --20.72M | ---- | ---- | --293K | --71K | ---- |
| Purchase of fixed assets | ---- | -11.20%-983K | ---505K | -8,740.00%-884K | ---- | 99.13%-10K | ---- | -4,323.08%-1.15M | ---- | 99.95%-26K |
| Sale of subsidiaries | --41.67M | ---- | ---- | ---- | ---- | ---- | ---- | 160.24%300K | --300K | ---498K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | 109.90%2.37M | ---23.95M | ---23.95M | ---- |
| Recovery of cash from investments | 59.87%1M | -98.85%3.74M | -99.58%628K | 46.61%325.48M | -9.15%149.64M | -56.39%222.01M | -41.18%164.71M | -49.02%509.09M | -26.49%280.02M | 2.48%998.68M |
| Cash on investment | ---- | 99.55%-1.49M | 99.18%-1.17M | -59.40%-328.39M | 3.83%-143.32M | 62.18%-206.01M | 47.37%-149.03M | 46.44%-544.65M | 42.93%-283.15M | 1.98%-1.02B |
| Other items in the investment business | ---- | -490.19%-1.63M | 589.08%8.27M | -63.24%418K | -34.99%1.2M | -90.83%1.14M | 136.30%1.85M | 1,588.96%12.4M | -194.32%-5.09M | 94.23%-833K |
| Adjustment items of investment business | ---- | ---- | ---- | ---1.52M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 495.93%43.04M | 236.56%79.51M | -74.42%7.22M | -364.21%-58.22M | -30.44%28.24M | 166.88%22.04M | 400.14%40.6M | -365.24%-32.95M | 107.11%8.12M | 91.99%-7.08M |
| Net cash before financing | -248.72%-80.19M | 137.10%35.59M | 139.63%53.92M | -315.46%-95.94M | 73.91%22.5M | 842.13%44.53M | 28,651.11%12.94M | 77.62%-6M | 100.03%45K | 81.44%-26.81M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | --6.44M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | --39.83M | --39.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | -663.49%-481K | ---176K | ---63K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -101.19%-458K | 506.47%38.64M | --38.59M | --6.37M | ---- | ---- | ---- | 17.25%-331K | ---- | 99.62%-400K |
| Effect of rate | 8,675.00%702K | -123.60%-1.49M | -99.93%8K | 1,257.30%6.33M | 720.91%11.16M | 111.88%466K | -97.58%-1.8M | -62.60%-3.92M | -253.20%-910K | -513.01%-2.41M |
| Net Cash | -187.18%-80.65M | 182.88%74.23M | 311.14%92.51M | -301.15%-89.57M | 73.91%22.5M | 803.33%44.53M | 28,651.11%12.94M | 76.73%-6.33M | 100.03%45K | 89.14%-27.21M |
| Begining period cash | 41.87%246.47M | 0.75%173.73M | 0.75%173.73M | 35.31%172.44M | 35.31%172.44M | -7.45%127.44M | -7.45%127.44M | -17.70%137.7M | -17.70%137.7M | -59.91%167.32M |
| Cash at the end | -37.45%166.53M | 176.33%246.47M | 29.18%266.25M | -48.27%89.2M | 48.72%206.1M | 35.31%172.44M | 1.28%138.58M | -7.45%127.44M | 494.50%136.83M | -17.70%137.7M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhi Bao Xin Qin Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.